Microfluidics

What is Microfluidics?
Microfluidics refers to the science and technology involved in manipulating tiny fluid volumes (ranging from nanoliters to attoliters) within microscale channels (typically tens to hundreds of microns). It is an emerging interdisciplinary field intersecting chemistry, fluid physics, microelectronics, new materials, biology, and biomedical engineering.
In the contemporary IVD (In-Vitro Diagnostics) sector, microfluidic technology serves as the foundation for developing Microfluidic Chips. These chips integrate basic operational units—such as sample preparation, reaction, separation, and detection—onto a single substrate at the micrometer scale, enabling the automation of the entire analytical process. The key advantages of microfluidic detection chips include minimal sample consumption, high throughput, rapid detection, ease of operation, multifunctional integration, compact size, and portability. The key to their widespread application lies in low-cost, large-scale molding techniques and high manufacturing precision.
A complete IVD microfluidic system comprises three essential elements: Reagents, Chips, and Instruments.
Reagents: The foundation of the assay methodology.
Microfluidic Chips: The core consumable carrier for sample processing, biochemical reactions, and analysis.
Analytical Instruments: Auxiliary tools for fluid control, temperature regulation, and signal acquisition.
These three elements are interdependent and mutually reinforcing.

The IVD and broader life sciences industry is a diagnostics market centered on the human body. It is characterized by diverse demands, extensive interdisciplinary overlap, and fragmented niche markets. Consequently, efficiency must be driven by specialized industrial division of labor—a trajectory that represents the future of China's IVD industry. Transforming technology into commercial commodities tests a company's mass manufacturing capabilities. This requires life science founders to build robust manufacturing teams capable of scaling products from "0 to 1," "1 to 100," and "100 to 10,000."
Suzhou Wongeny: A Pioneer in Automation
Established in Suzhou in 2018, Wongeny is a global pioneer in fully automated microfluidic chip production. Recognized as a National High-Tech Enterprise and a Unicorn Cultivation Enterprise, Wongeny is a key investment focus of the Suzhou Municipal Government, having secured multiple rounds of funding from state-owned capital and market-oriented funds.
With years of dedicated R&D, Wongeny offers integrated OEM/ODM/CDMO services spanning Life Science Instruments + Biochip Consumables + Automated Production Equipment. This unique tripartite capability allows us to meet clients' multifaceted needs across the entire lifecycle—from R&D and manufacturing to mass production. Our services cover IVD, medical devices, life sciences, and biopharmaceuticals, specializing in high-value bio-consumables, instrument R&D, process development, mold making, and mass production.
Core Competencies
1. Life Science Instruments
We possess diverse R&D capabilities covering:
Molecular POCT platforms
Pathogen detection pipeline automation systems
Single-molecule immunoassay analyzers
Fully automatic dry multi-function analyzers
Veterinary multi-function analyzers
Zebrafish series lab instruments
Microfluidic biochemical analyzers
Chemiluminescence immunoassay analyzers
Ultrasonic lysis instruments
Automated FFPE nucleic acid extraction systems
DNA methylation pre-processing workstations
Automated sample aliquoting systems
Standard instrument modules
2. Biochip Consumables
Life science instruments require biochips as carriers for reagent addition; only when combined do they realize their full utility. Wongeny offers comprehensive manufacturing capabilities, including:
Mold design and manufacturing
Precision machining & injection molding
3D printing & membrane lamination
Precision die-cutting
Specialized Injection Molding: Conducted in ISO Class 10,000 (Class D) cleanrooms, featuring two-shot molding, microarray molding, and microchannel molding. We handle hydrophilic/hydrophobic surface treatments and process various polymers (COC, COP, PP, PS, PMMA, PC, Silicone Rubber).
·
3. Automation Production Equipment
To achieve mass production of biochips, industrial automation is essential to replace manual labor, ensuring capacity and quality. Wanguiyuan provides specialized equipment for the medical industry, including:
Microfluidic chip production lines
Bioreagent filling & sealing systems
Interventional sterile device assembly lines
Auto-injector assembly lines
Inhalation drug delivery device lines
Vial washing machines & lyophilizers
Lyosphere dispensing & sorting systems
Automated cartoning & labeling machines
Our process modules encompass over 30 customized techniques, such as laser welding/cutting, ultrasonic welding, thermo-compression bonding, UV bonding, resin adhesive bonding, reagent embedding, lyosphere QC, microsphere sorting/synthesis, FPC packaging, and final packaging.
Wongeny Intelligent Automation
Leveraging core technologies accumulated in biomedicine, Wongeny has overcome key bottlenecks in microfluidic industrialization, achieving true large-scale mass production and offering one-stop microfluidic chip services.
R&D Expertise: Professional teams with extensive experience in microfluidic project design and verification.
Quality Assurance: Certified under ISO 13485, ensuring high-precision, high-standard manufacturing.
GMP Facilities: Class 10,000 GMP workshops guaranteeing a medical-grade production environment.
Modular Design: Systematized manufacturing processes allow for flexible module combination based on client needs, ensuring efficient batch production.
Market Strategy & Vision
In the post-pandemic era, enterprises are focusing on cost reduction and R&D efficiency. Strategies such as M&A and contract development are becoming mainstream. Wanguiyuan focuses solely on one mission: providing holistic manufacturing solutions for IVD products. By unifying resources for instruments, chips, and reagents, we eliminate inter-departmental friction and supplier delays, bringing products to market faster and at lower cost.
Microfluidics is destined for deep industrial integration. Wongeny’s strategy combines cutting-edge R&D with scalable mass production. We aim not just to be a passive CDMO supplier, but an active leader in frontier technology, enhancing our clients' market competitiveness.


